.

Validation and feasibility testing of a novel questionnaire to identify barriers to medication adherence

Principal Investigator: Debi Bhattacharya, University of East Anglia

  • Between a third and a half of patients prescribed medicines for long term conditions do not take them as prescribed. 
  • There is no effective tool for determining patient barriers to adherence in order to guide implementation of appropriate support. 
  • We report testing of the Identification of Medication Adherence Barriers Questionnaire (IMAB-Q) which was developed by the research team to identify patient barriers to adherence in routine care 
  • Nine pharmacies distributed the IMAB-Q to patients. A small sample of patients completed the questionnaire twice to test reliabilityPharmacists used IMAB-Q in medicines use reviews (MURs) to explore feasibility in practice and were interviewed to capture their thoughts and experiences of using it. 
  • The pharmacists thought IMAB-Q could be useful for identifying adherence barriers in an MUR and especially for raising topics not routinely discussed.  
  • A valid response to all 30 IMAB-Q questions was obtained from 608 (92.12%) completed questionnaires indicating good readability. The most common adherence barriers were emotions and beliefs about consequences which are not topics routinely discussed during MURs. 
  • Analysis defined a 10 item IMAB-Q which accurately identified non-adherent patients as they were significantly (p = 0.001) more likely to report barriers to adherence. The IMAB-Q was reliable when repeated.  
  • In the future we plan to test whether the 10 item IMAB-Q helps pharmacists to select appropriate interventions for non-adherent patients to improve health outcomes. We intend that IMAB-Q be used as a standard tool to guide and thus improve MURs and other adherence related consultations.

This project ran from June 2014 to May 2016. The final report is available here.

Share and Enjoy !

0Shares
0 0